Substrate specificity of the human UDP-glucuronosyltransferase UGT2B4 and UGT2B7 - Identification of a critical aromatic amino acid residue at position 33

被引:39
作者
Barre, Lydia
Fournel-Gigleux, Sylvie
Finel, Moshe
Netter, Patrick
Magdalou, Jacques
Ouzzine, Mohamed
机构
[1] Univ Nancy 1, CNRS, UMR 7561, Fac Med, F-54505 Vandoeuvre Les Nancy, France
[2] Univ Helsinki, Fac Pharm, Drug Discovery & Dev Technol Ctr, FIN-00014 Helsinki, Finland
关键词
site-directed mutagenesis; substrate specificity; UDP-glucuronosyltransferase; UGT2B4; UGT2B7;
D O I
10.1111/j.1742-4658.2007.05670.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human UDP-glucuronosyltransferase (UGT) isoforms UGT2B4 and UGT2B7 play a major role in the detoxification of bile acids, steroids and phenols. These two isoforms present distinct but overlapping substrate specificity, sharing common substrates such as the bile acid hyodeoxycholic acid (HDCA) and catechol-estrogens. Here, we show that in UGT2B4, substitution of phenylalanine 33 by leucine suppressed the activity towards HDCA, and impaired the glucuronidation of several substrates, including 4-hydroxyestrone and 17-epiestriol. On the other hand, the substrate specificity of the mutant UGT2B4F33Y, in which phenylalanine was replaced by tyrosine, as found at position 33 of UGT2B7, was similar to wild-type UGT2B4. In the case of UGT2B7, replacement of tyrosine 33 by leucine strongly reduced the activity towards all the tested substrates, with the exception of 17-epiestriol. In contrast, mutation of tyrosine 33 by phenylalanine exhibited similar or even somewhat higher activities than wild-type UGT2B7. Hence, the results strongly indicated that the presence of an aromatic residue at position 33 is important for the activity and substrate specificity of both UGT2B4 and UGT2B7.
引用
收藏
页码:1256 / 1264
页数:9
相关论文
共 22 条
[11]  
JIN CJ, 1993, J PHARMACOL EXP THER, V264, P475
[12]   The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers [J].
Kurkela, M ;
Hirvonen, J ;
Kostiainen, R ;
Finel, M .
BIOCHEMICAL PHARMACOLOGY, 2004, 68 (12) :2443-2450
[13]   Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs) [J].
Kurkela, M ;
García-Horsman, JA ;
Luukkanen, L ;
Mörsky, S ;
Taskinen, J ;
Baumann, M ;
Kostiainen, R ;
Hirvonen, J ;
Finel, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) :3536-3544
[14]   Expression and functional domains of rabbit liver UDP-glucuronosyltransferase 2B16 and 2B13 [J].
Li, Q ;
Lou, XJ ;
Peyronneau, MA ;
Straub, PO ;
Tukey, RH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3272-3279
[15]  
MACKENZIE PI, 1990, J BIOL CHEM, V265, P3432
[16]   Substrate gating confers steroid specificity to estrogen sulfotransferase [J].
Petrotchenko, EV ;
Doerflein, ME ;
Kakuta, Y ;
Pedersen, LC ;
Negishi, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :30019-30022
[17]   Structural and functional studies of UDP-glucuronosyltransferases [J].
Radominska-Pandya, A ;
Czernik, PJ ;
Little, JM ;
Battaglia, E ;
Mackenzie, PI .
DRUG METABOLISM REVIEWS, 1999, 31 (04) :817-899
[18]   Human UDP-glucuronosyltransferase 2B7 [J].
Radominska-Pandya, A ;
Little, JM ;
Czernik, PJ .
CURRENT DRUG METABOLISM, 2001, 2 (03) :283-298
[19]  
RITTER JK, 1992, J BIOL CHEM, V267, P3257
[20]   2 HUMAN LIVER CDNAS ENCODE UDP-GLUCURONOSYLTRANSFERASES WITH 2 LOG DIFFERENCES IN ACTIVITY TOWARD PARALLEL SUBSTRATES INCLUDING HYODEOXYCHOLIC ACID AND CERTAIN ESTROGEN DERIVATIVES [J].
RITTER, JK ;
CHEN, F ;
SHEEN, YY ;
LUBET, RA ;
OWENS, IS .
BIOCHEMISTRY, 1992, 31 (13) :3409-3414